Drugs / MBC-11
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02673060 | Jul 2014 → Nov 2015 | bone neoplasm | Osteros Biomedica Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MBC-11 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02673060 ↗ |
| Modality | Other / unclassified | “MBC-11 is a first-in-class conjugate” PMID 30413669 ↗ Nov 2018 |